Literature DB >> 10854289

Impaired proteasome function in Alzheimer's disease.

J N Keller1, K B Hanni, W R Markesbery.   

Abstract

Inhibition of proteasome activity is sufficient to induce neuron degeneration and death; however, altered proteasome activity in a neurodegenerative disorder has not been demonstrated. In the present study, we analyzed proteasome activity in short-postmortem-interval autopsied brains from 16 Alzheimer's disease (AD) and nine age- and sex-matched controls. A significant decrease in proteasome activity was observed in the hippocampus and parahippocampal gyrus (48%), superior and middle temporal gyri (38%), and inferior parietal lobule (28%) of AD patients compared with controls. In contrast, no significant decrease in proteasome activity was observed in either the occipital lobe or the cerebellum. The loss of proteasome activity was not associated with a decrease in proteasome expression, suggesting that the proteasome may become inhibited in AD by a posttranslational modification. Together, these data indicate a possible role for proteasome inhibition in the neurodegeneration associated with AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854289     DOI: 10.1046/j.1471-4159.2000.0750436.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  255 in total

Review 1.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14.

Authors:  Bula J Bhattacharyya; Scott M Wilson; Hosung Jung; Richard J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-09       Impact factor: 4.249

3.  Mild heat stress stimulates 20S proteasome and its 11S activator in human fibroblasts undergoing aging in vitro.

Authors:  Rasmus Beedholm; Brian F C Clark; Suresh I S Rattan
Journal:  Cell Stress Chaperones       Date:  2004-03       Impact factor: 3.667

4.  Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity.

Authors:  David X Medina; Antonella Caccamo; Salvatore Oddo
Journal:  Brain Pathol       Date:  2011-03       Impact factor: 6.508

5.  Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.

Authors:  Pradeep Kurup; Yongfang Zhang; Jian Xu; Deepa V Venkitaramani; Vahram Haroutunian; Paul Greengard; Angus C Nairn; Paul J Lombroso
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

6.  Initiation and propagation of neurodegeneration.

Authors:  Christian Haass
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

7.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

8.  Age-related memory deficits are associated with changes in protein degradation in brain regions critical for trace fear conditioning.

Authors:  Brooke N Dulka; Shane E Pullins; Patrick K Cullen; James R Moyer; Fred J Helmstetter
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

Review 9.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

10.  Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.

Authors:  Xiangyou Hu; Qi Shi; Xiangdong Zhou; Wanxia He; Hong Yi; Xinghua Yin; Marla Gearing; Allan Levey; Riqiang Yan
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.